Literature DB >> 30500529

Putting the Immunologic Brakes on Cancer.

Jedd Wolchok1.   

Abstract

The 2018 Nobel Prize in Medicine and Physiology has been awarded to James P. Allison and Tasuku Honjo for their discovery of cancer therapy by inhibition of negative immune regulation. These insights have given rise to a class of medicines that have now entered routine use in the treatment of advanced cancers and have provided a foundation for additional exploration and discovery of pathways critical to modulating the immune response to cancer.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2018        PMID： 30500529     DOI： 10.1016/j.cell.2018.11.006

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


  23 in total

1.  Pancreatic cancer hidden in plain sight.

Authors:  Anirban Maitra
Journal:  Nature       Date:  2020-05       Impact factor: 49.962

Review 2.  Intratumoural immunotherapy: activation of nucleic acid sensing pattern recognition receptors.

Authors:  Sudhir Agrawal; Ekambar R Kandimalla
Journal:  Immunooncol Technol       Date:  2019-10-16

Review 3.  Targeting the epigenetic regulation of antitumour immunity.

Authors:  Simon J Hogg; Paul A Beavis; Mark A Dawson; Ricky W Johnstone
Journal:  Nat Rev Drug Discov       Date:  2020-09-14       Impact factor: 84.694

4.  Visualization of human T lymphocyte-mediated eradication of cancer cells in vivo.

Authors:  Xingkang He; Xin Yin; Jing Wu; Stina L Wickström; Yanhong Duo; Qiqiao Du; Shuhang Qin; Shuzhong Yao; Xu Jing; Kayoko Hosaka; Jieyu Wu; Lasse D Jensen; Andreas Lundqvist; Alexander I Salter; Lars Bräutigam; Wei Tao; Yuguo Chen; Rolf Kiessling; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-28       Impact factor: 11.205

Review 5.  Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways.

Authors:  Lukas Kraehenbuehl; Chien-Huan Weng; Shabnam Eghbali; Jedd D Wolchok; Taha Merghoub
Journal:  Nat Rev Clin Oncol       Date:  2021-09-27       Impact factor: 66.675

Review 6.  Protein Arginine Methylation: An Emerging Modification in Cancer Immunity and Immunotherapy.

Authors:  Weijing Dai; Jianguo Zhang; Siqi Li; Fajian He; Qiao Liu; Jun Gong; Zetian Yang; Yan Gong; Fang Tang; Zhihao Wang; Conghua Xie
Journal:  Front Immunol       Date:  2022-04-14       Impact factor: 8.786

Review 7.  Lifting the innate immune barriers to antitumor immunity.

Authors:  Carla V Rothlin; Sourav Ghosh
Journal:  J Immunother Cancer       Date:  2020-04       Impact factor: 13.751

Review 8.  Role of Exosomes in the Regulation of T-cell Mediated Immune Responses and in Autoimmune Disease.

Authors:  Alberto Anel; Ana Gallego-Lleyda; Diego de Miguel; Javier Naval; Luis Martínez-Lostao
Journal:  Cells       Date:  2019-02-12       Impact factor: 6.600

Review 9.  Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities.

Authors:  Stephen P Hack; Andrew X Zhu; Yulei Wang
Journal:  Front Immunol       Date:  2020-11-05       Impact factor: 7.561

10.  The importance of developing therapies targeting the biological spectrum of metastatic disease.

Authors:  Andries Zijlstra; Ariana Von Lersner; Dihua Yu; Lucia Borrello; Madeleine Oudin; Yibin Kang; Erik Sahai; Barbara Fingleton; Ulrike Stein; Thomas R Cox; John T Price; Yasumasa Kato; Alana L Welm; Julio A Aguirre-Ghiso
Journal:  Clin Exp Metastasis       Date:  2019-05-17       Impact factor: 5.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.